B&L Gains PureVision Insight From Ciba Vision's Ophthalmic Panel Review
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb's PureVision 30-day continuous wear contact lenses could undergo review by FDA's Ophthalmic Devices Panel as early as Sept. 20-21.